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A total of 139 guineapigs were used to study the immune response and its modulation induced by
Mycobacterium avium complex (MAC) and M. fortuitum complex strains obtained from different
sources in the south Indian BCG trial area. The guineapigs were divided into groups and some were
directly sensitised/immunised with different MAC strains, M. fortuitum complex strain or BCG and
others were sensitised with MAC or M. fortuitum complex and then immunised with BCG. The
resulting delayed type hypersensitivity (DTH) response in the different groups of guineapigs was
studied by skin tests using PPD-RT23 and PPD-B, and protective response was studied by challeng-
ing the guineapigs with a south Indian low virulent strain of M. tuberculosis and enumerating the
bacilli in spleen at different points of time. The 3 strains of MAC induced similar low levels of DTH
to PPD-RT23 but much higher and varying levels of DTH to PPD-B. MAC strains from soil and
sputum induced different levels of immune modulation during subsequent immunisation with BCG
on the DTH response to PPD-RT23 and PPD-B. At 2 wk after challenge, 23.8, 81 and 90.5 per cent
protection was induced by the standard strain, soil isolate and sputum isolate of MAC, respectively,
while 33.3 per cent protection was induced by the M. fortuitum complex strain compared to the
protection induced by BCG alone. Prior exposure to MAC or M. fortuitum complex did not have
any modulatory effect on the protective immunity due to BCG at this time point. However, at 6
wk after challenge, while the guineapigs immunised with BCG were protected, modulation of the
protective response resulting from BCG was observed in the guineapigs sensitised with MAC and
M. fortuitum from soil.
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The nontuberculous mycobacteria (NTM) are ubiq-
uitous in the environment1. Exposure of man to these
organisms results in an immunologically effective
contact as revealed by skin-test response to myco-
bacterial antigens2-4. As far back as 1962, Edwards
and others5 had suggested that mycobateria in the
environment may have a bearing on the low-grade
sensitivity often observed in the human population
and that infection with such mycobacteria may have
considerable influence on the course of subsequent
infection with virulent tubercle bacilli. Such an
immunomodulation has also been hypothesised to be
one of the reasons for the failure of BCG to protect
against adult-type pulmonary tuberculosis in the
south Indian BCG trial6
In the south Indian BCG trial, the study popula-
tion had a high level of scnsitisation to PPD-B7.
Further, nearly 20 per cent of the NTM isolated from
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sputum samples of subjects residing in this area
belonged to the M. avium complex8. In a study re-
cently reported by us9, organisms of the M. avium
complex (MAC) and M. fortuitum complex were
found to be the predominant isolates from soil, wa-
ter. house-dust and sputum samples in the south
Indian BCG trial area. Subsequent to this, we carried
out the present investigation in the guineapig model
to study the extent of immune response and
immunomodulation induced by MAC isolates ob-
tained from sputum and environment and a soil iso-
late of the M. fortuitum complex in terms of delayed
type hypersensitivity (DTH) response to mycobacte-
rial skin-test antigens, PPD-RT23 and PPD-B, and
protective response against challenge infection by
south Indian low virulent (SILV) strain10 of M. tu-
berculosis.
Material & Methods
The investigation was carried out in three experi-
ments; the immune response resulting from exposure
to MAC organisms was studied in the first experi-
ment. immunomodulation by MAC organisms was
studied in the second experiment. and the immune
response and immunomodulation resulting from ex-
posure to M. fortuitum complex organisms were stud-
ied in the third experiment.
Mycobacterial strains : The following strains were
used in the experiments: (i) TMC 1403- standard
strain of M. intracellulare (referred to as MACsd in
text, tables and figures). (ii) MAC from soil
(MACso)-strain A55/4 isolated from soil sample
collected in the south Indian BCG trial area. (iii)
MAC from sputum (MACsp)- strain TS11515 iso-
lated from sputum sample of a symptomatic subject
with no M. tuberculosis isolation residing in the
south Indian BCG trial area. (iv) M. fortuitum - strain
A33/1a isolated from soil sample collected in the
south Indian BCG trial area. (v) BCG- a sub-culture
on LJ from a fresh ampoule of BCG (BCG Labora-
tory, Madras). (vi) M. tuberculosis south Indian low
virulent strain (SILV)- strain N9431 isolated from a
pulmonary tuberculosis patient from the south Indian
BCG trial area. established as a low virulent strain in
guineapigs and maintained on LJ. This strain was
passaged in guineapigs before each experiment.
Guineapigs : A total of 139 random bred guineapigs
of the M strain, in the weight range 450-600g, main-
tained at the Tuberculosis Research Centre (TRC),
Madras animal house, were used in the experiments.
Immunisation and challenge : In the 1 st experiment.
there were 5 groups of 8 animals each which were
immunised/sensitised with BCG or the different
strains of MAC and then challenged with SILV as
shown in Table I. In the 2nd experiment. there were
5 groups of 15 animals each which were sensitised
with different strains of MAC prior to immunisation
with BCG and challenge with SILV as shown in
Table II. In the 3rd experiment, there were 4 groups
of 6 animals each which were immunised/sensitised
with BCG or M. fortuitum alone or sensitised with
M. fortuitum prior to immunisation with BCG, fol-
lowed by challenge with SILV as shown in Table III.
For sensitisation and immunisation with MAC. M.
fortuitum and BCG. 1 mg moist weight of the organ-
isms [107-109] colony forming units (cfu)] in 0.1 ml
sterile distilled water was injected intradermally in
the inner side of the thigh.
For challenge with SILV, 1 mg moist weight of
organism ( 107cfu) in 0.5ml sterile distilled water was
injected intramuscularly in the thigh.
Skin tests : One week before challenging with SILV,
all the animals were simultaneously skin-tested with
5 IU of PPD-RT23 (BCG Laboratory, Guindy, Ma-
dras) and 50 TU of PPD-B (BCG Laboratory, Guindy,
Madras) as standardised in preliminary experiments,
by intradermal injection of 0.1 ml of each antigen on
the shaved dorsal flanks and were read at 24 h11.
Bacterial enumeration in spleen (BE-spleen) : Fol-
lowing challenge with SILV, 4 guineapigs from each
group were sacrificed using chloroform vapour at 2
and 6 wk in experiment 1, 5 guineapigs from each
group at 2, 6 and 12 wk in experiment 2 and 3
guineapigs from each group at 2 and 6 wk in experi-
ment 3. Spleens were collected aseptically and
homogenised in 5 ml of sterile distilled water using
a motorised Teflon grinder. From this homogenate
and 5 serial 10-fold dilutions, 10 µl were inoculated
into 2 slopes of Lownstein-Jensen (LJ) medium
each. The slopes were read after 4 wk of incubation
at 37°C. The log10 cfu of SILV in spleen for each
animal was calculated based on the number of colo-
nies obtained on LJ slopes.
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Table I. Design of experiment 1 : Immune response induced by MAC organisms
Time Group 1 Group 2 Group 3 Group 4
(wk) n=8 n=8 n=8 n=8
Control BCG-SILV MACsd-SILV MACso-SILV
0 BCG MACsd MACso
5 ST ST ST ST
6 SILV SILV SILV SILV
Bacterial enumeration in spleen was done in each group at 2  and 6 wk after SILV challenge
BCG, Bacille Calmette Guerin.
MACsd, Standard strain of M. intracellulare, TMC 1403.
MACso, M. avium strain isolated from soil.
MACsp, M. avium strain isolated from sputum.
ST, Skin-test with PPD-RT23 and PPD-8.
SILV, South Indian low virulent strain of M. tuberculosis
Group 5
n=8
MACsp-SILV
MACsp
ST
SILV
Table II. Design of experiment 2 : immunomodulation by MAC organisms
Time Group 1 Group 2 Group 3 Group 4
(wk) n=15 n=15 n=15 n=15
Control BCG-SILV MACsd-BCG-SILV MACso-BCG-SILV
0 MACsd MACso
6 BCG BCG BCG
1 1 ST ST ST ST
12 SILV SILV SILV SILV
Bacterial enumeration in spleen was done in each group at 2, 6 and 12 wk after SILV challenge
MACsd, Standard strain of M. intracellualre, TMC 1403.
MACso, M. avium strain isolated from soil.
MACsp, M. avium strain isolated from sputum,
BCG, Bacille Calmette Guerin.
ST, Skin-test with PPD-RT23 and PPD-R.
SILV, South Indian low virulent strain of M. tuberculosis
Group 5
n=15
MACsp-BCG-SILV
MACsp
BCG
ST
SILV
Statistical analysis : The results arc expressed as
mean ± SD. Chi square tests for proportions. t-test
for comparing the mean values of two groups and
ANOVA for comparing more than two groups were
used to test the significance of the data. The multiple
comparison tests were also carried out along with
ANOVA to categorise the group means. Log trans-
formations were used to stabilise the variations in the
data before performing statistical analysis. The SPSS/
PC+ software package was used to perform the sta-
tistical analysis.
Results
DTH response induced by MAC : The results of the
skin tests done using PPD-RT23 and PPD-B to study
DTH induced by MAC organisms are given in Fig.
1. The DTH to PPD-RT23 and PPD-R in animals in
the control group was negligible with the mean reac-
tion being 0.4±0.9mm and 0.4±0.6mm for PPD-RT23
and PPD-B, respectively.
The skin test response to PPD-RT23 in the ani-
mals immunised with BCG (mean 7.0±2.0mm) was
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Fig. 1. Mean (mm) reaction to PPD-RT33 and PPD-B in the guineapigs exposed to different strains of MAC or BCG.
1. Control : Control animals, 2. BCG : Bacille Calmette Guerin, 3. MACsd : Standard strain of M. intracellulare, TMC 1403.
4. MACso : M. avium complex strain isolated from soil. 5. MACsp : M. avium complex strain isolated from sputum.
Table III. Design of experiment 3 : immune response and
immunomodulation resulting from exposure to M. fortuitum
complex
Time Group 1 Group 2 Group 3 Group 4
(wk) n=6 n=6 n=6 n=6
Control BCG- M. fortuitum M. fortuitum-
SILV SILV BCG-SILV
0 M. fortuitum
6 BCG M. fortuitum BCG
1 1 ST ST ST ST
12 SILV SILV SILV SILV
Bacterial enumeration in spleen was done in each group at 2 and 6
wk alter SILV challenge
BCG, Bacille Calmette Guerin,
ST, Skin-test with PPD-RT23 and PPD-B,
SILV, South Indian low virulent strain of M. tuberculosis
significantly higher (P<0.03) compared to the re-
sponses observed in the animals immunised with any
of the three MAC strains which were not signifi-
cantly different from each other. Compared to that in
the control group, the response to PPD-RT23 was
significantly higher in the animals immunised with
BCG (P<0.0001) or with MACsp (mean 1.8± 1.4mm;
P=0.04) but not in the animals immunised with
MACsd (mean 3.1±4.0mm) or with MACso (mean
1.4±1.0mm). Thus, the DTH response to PPD-RT23
was maximum in the animals immunised with BCG
followed by the response in the animals immunised
with MACsd, MACsp, MACso and the control ani-
mals in the order of decreasing reactivity.
The skin test response to PPD-B was also signifi-
cantly higher (P<0.01) in the sensitised animals
(means 3.6±2.7mm, 11.1±3.2mm, 9.9±2.9mm and
5.1±2.1mm in the animals sensitised with BCG,
MACsd, MACso and MACsp, respectively) as com-
pared to that observed in the control animals. The
skin test response to PPD-B in the animals immunised
with MACsd or MACso was similar and was signifi-
cantly higher than the response in the animals
immunised with BCG or with MACsp (P<0.001).
Thus. the DTH response to PPD-B was maximum in
the animals immunised with MACsd followed by the
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response in the animals immunised with MACso,
MACsp, BCG and the control animals in the order of
decreasing reactivity.
Modulation of DTH response induced by MAC : The
results of the skin tests done using PPD-RT23 and
PPD-B to study modulation of DTH are given in Fig.
2. The DTH in animals in the control group was
again negligible with the mean reaction being
0.2±0.8mm and 0.4±1.1 mm for PPD-RT23 and PPD-
B, respectively. Compared to this group, significant
levels of DTH (P<0.01 ) to both PPD-RT23 and PPD-
B were seen in the animals immunised with BCG
alone (means 8.6±4.2mm for PPD-RT23 and
4.3±3.1mm for PPD-B) or exposed to different strains
of MAC prior to immunisation with BCG (means
9.5±2.6mm, 5.9±4.2mm, 9.6±3.0mm for PPD-RT23,
and 6.6±3.3mm, 3.0±2.7mm and 6.0±3.6mm for
PPD-B in animals sensitised with MACsd, MACso
and MACsp, respectively).
However, among the sensitised and/or immunised
guineapigs while the skin-test response in animals
sensitised with MACsd or MACsp before
immunisation with BCG was similar to that in the
animals immunised with BCG without prior
sensitisation for both PPD-RT23 and PPD-B, a sig-
nificantly (P<0.05) lower skin test response to both
PPD-RT23 and PPD-B was seen in animals pre
sensitised with MACso.
DTH response and modulation of DTH response
induced by M. fortuitum complex : The results of the
skin tests done using PPD-RT23 and PPD-B to study
the DTH induced by M. fortuitum complex are given
in Fig 3. The DTH in animals in the control group
was negligible at 48 h (1.7±2.8 and 0.8+1.2mm,
respectively,  for PPD-RT23 and PPD-B). Compared
to the control animals. significantly higher DTH re-
sponses to PPD-RT23 was observed in all the other
groups (P=0.05). On the other hand, the DTH re-
sponse to PPD-B in the animals sensitised with M.
fortuitum prior to immunisation with BCG
(5.7±3.6mm) was significantly higher than that in
the control animals (P=0.03) and in the animals
Fig. 2. Mean (mm) reaction to PPD-RT23 and PPD-H in the guineapigs exposed to different strains of MAC or BCG.
1. Control : Control animals, 2. BCG : Bacille Calmette Guerin, 3. MACsd-BCG : Standard strain of M. intracellulare,  TMC
1403 followed by BCG, 4. MACso-BCG : M. avium complex strain isolated from soil followed by BCG, 5. MACsp-BCG :
M. avium complex strain isolated from sputum followed by BCG.
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Fig. 3. Mean (mm) reaction to PPD-RT23 and PPD-R in the guineapigs exposed to BCG, M. fortuitum or M. fortuitum followed
by BCG.
1. Control : Control animals, 2. BCG : Bacille Calmette Guerin, 3. M. fortuitum- BCG : M. fortuitum followed by BCG.
immuniscd with M. fortuitum alone (1.8±2.7mm)
(P=0.03) but not significantly different from that in
the animals immunised with BCG (2.8±2.2mm).
Protective response induced by MAC : The results of
BE-spleen in the experiment carried out to estimate
protective response against challenge infection with
SILV in the guineapigs exposed to different strains
of MAC or BCG arc given in Fig. 4.
At 2 wk after challenge, the log10 cfu of SILV in
the spleen was high (4.8±0.6) in the control animals.
Compared to this group, the count was significantly
lower (P=0.002) in the animals immunised with BCG
(2.7±0.5) indicating that BCG elicited a good protec-
tive response. Considering this reduction of 2.1 log10
cfu in the animals immunised with BCG as 100 per
cent protection. 23.8 per cent (4.3±0.4), 81 per cent
(3.1±2.1) and 90.5 per cent (2.9±2.0) protection was
seen in the animals exposed to MACsd, MACso and
MACsp, respectively. However, the counts in the
animals immunised with the different strains of MAC
were not significantly different from that in the con-
trol animals.
At 6 wk after challenge, SILV could not be de-
tected in the spleen of any of the animals immunised
with BCG. In all the other groups. detectable num-
bers of SILV were present at least in some of the
animals in each group. The mean counts in the ani-
mals exposed to MACsp (1.9±2.2) and MACso
(0.9±1.7) were higher than that in the control ani-
mals (0.6±1.2) which was similar to the count in the
animals exposed to MACsd (0.6±1.2). However, the
mean counts in these groups were not significantly
different from each other or from that in the control.
In all animals other than those immunised with
MACsp there was marked reduction (P<0.01) in the
counts at 6 wk after challenge as compared to the
counts at 2 wk after challenge.
Modulation of protective response induced by MAC :
At 2 wk after challenge, the log10 cfu of SILV in
spleen was high (5.3±0.9) in the control animals and
compared to this group, the count was significantly
(P<0.01 ) lower in the animals immunised with BCG
without prior sensitisation (2.0±1.9; Fig 5) indicat-
ing that BCG elicited a good protective response.
Considering this as 100 per cent protection, 97 per
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Fig. 4. Bacterial enumeration in spleen in the guineapigs exposed to different strains of MAC or BCG.
1. Control : Control animals, 2. BCG : Bacille Calmette Guerin, 3. MACsd : Standard strain of M. intracellulare, TMC 1403,
4. MACso : M. avium complex strain isolated from soil, 5. MACsp : M. avium complex strain isolated from sputum.
cent (2.1±0.3), 103 per cent (1.9±1.8) and 84.8 per
cent (2.5±1.5) protection was seen in the animals
immunised with BCG after prior sensitisation with
MACsd, MACso and MACsp, respectively. The
counts in the animals sensitised with MACsd, MACso
or MACsp prior to immunisation with BCG were not
significantly different from that observed in the ani-
mals immunised with BCG without prior
sensitisation. indicating that prior exposure to MAC
organisms did not have any modulatory effect on the
protective response elicited by subsequent BCG
immunisation during the early course of challenge
infection in guineapigs studied.
At 6 wk after challenge, data for 1 animal each
from groups 2, 3 and 4 and 2 animals from group 5
were not available because of death not due to tuber-
culosis. In the remaining animals. the challenge or-
ganisms could not be detected in the spleens of ani-
mals immunised with BCG without prior
sensitisation or sensitised with MACsd or MACsp
prior to immunisation with BCG. However, in 2 of
4 animals sensitised with MACso prior to
immunisation with BCG, the challenge organisms
were still present in the spleen, indicating a modula-
tory effect and the mean counts in these animals
(1.6±1.9) was slightly higher but not significantly
different from that observed in the control animals
(0.5±1.1).
At 12 wk after challenge, data for 1 animal-each
from groups 3 and 4 were not available because of
death not due to tuberculosis. In the remaining ani-
mals. in all the groups including the controls, the
challenge organisms could not be detected in the
spleen.
Protective response and modulation of protective
response induced by M. fortuitum complex : The
results of BE-spleen in the experiment carried out to
estimate protective response and its modulation
against challenge infection with SILV in the
guineapigs immunised with M. fortuitum or sensitised
with M. fortuitum prior to immunisation with BCG
are given in Fig. 6. Data for 1 animal from group 2
was not available because of death not due to tuber-
culosis.
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Fig. 5. Bacterial enumeration in spleen in the guineapigs exposed to different strains of MAC or BCG.
1. Control : Control animals, 2. BCG : Bacille Calmette Guerin, Not visible at 2, 6, and 12 wk., 3. MACsd-BCG : Standard strain
of M. intracellulare, TMC 1403 followed by BCG, 4. MACso-BCG : M. avium complex strain isolated from soil followed
by BCG, 5. MACsp-BCG : M. avium complex strain isolated from sputum followed by BCG.
At 2 wk after challenge, the log10 cfu of SILV in
the spleen was high (3.9±0.3) in the control animals.
Compared to this group, the counts were lower in the
animals immunised with BCG ( 1.8±1.5), or with M.
fortuitum (3.2±0.8) and in the animals sensitised
with M. fortuitum prior to immunisation with BCG
(1.9±2.0) but the differences were not significant.
Thus. considering the reduction of 2.1 logl0 cfu in the
animals immunised with BCG as 100 per cent pro-
tection, 33.3 per cent protection was seen in the
animals immunised with M. fortuitum and 95.2 per
cent protection in the animals immunised with BCG
after prior sensitisation with M. fortuitum.
At 6 wk after challenge, while SILV could not be
detected in the spleen of the animals immunised with
BCG, viable SILV could be detected in 1 of 3 ani-
mals in the group either immunised with M. fortuitum
or sensitised with M. fortuitum prior to immunisation
with BCG and the mean counts in these animals
(0.9±1.6) was similar to that in the control animals
(0.9±1.6).
Discussion
The results of the present study showed that in
guineapigs immunised with MAC, the skin test re-
sponse to PPD-B was greater than that to PPD-RT23
which would be expected since the DTH response to
homologous antigens is greater than that to heterolo-
gous antigens3,4.
Some differences were observed in the DTH re-
sponse induced by the different strains of MAC
tested. The level of DTH response to PPD-B. the
homologous antigen, was significantly lower in the
animals immunised with MAC from sputum as com-
pared to that in animals immunised with either the
standard strain, TMC 1403 or MAC from soil. MAC
obtained from soil and sputum samples also induced
different levels of immune modulation on the DTH
response. The immune modulation by prior
sensitisation with MAC of the DTH resulting from
immunisation with BCG in terms of reduced re-
sponse to PPD-RT23 and PPD-B was highest in the
animals which had been sensitised with MAC from
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Fig. 6. Bacterial enumeration in spleen in the guineapigs exposed BCG, M. fortuitum or M. fortuitum followed by BCG.
1. Control : Control animals, 2. BCG : Bacille Calmette Guerin, 3. M. fotuitum- BCG : M. fortuitum followed by BCG.
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soil. It has been shown that prior sensitisation of
guineapigs with M. simiae leads to a reduction in the
DTH response to PPD-S12 resulting from subsequent
vaccination with BCG, which was termed as ‘im-
mune modulation’, while there is no apparent effect
on the protective response11. Brown et al13 have also
shown that depending on the timing of exposure of
mice in vivo to M. vaccae before BCG vaccination.
oral administration of this species of environmental
mycobacteria can either enhance. mask or interfere
with the expression of sensitisation with BCG.
In the experiment carried out to study the DTH
induced by organisms of the M. fortuitum complex
from soil, M. fortuitum induced the same level of
DTH response to both PPD-RT23 and PPD-B as
BCG, and appeared to boost the DTH response to
PPD-B in the animals subsequently immunised with
BCG. This may be due to the presence of antigens
common to both M. fortuitum and BCG in PPD-B.
With regard to protective immune response in-
duced by nontuberculous mycobacteria, in Palmer
and Long’s extensive study using more than 1000
guincapigs and survival time as a measure of protec-
tion. it was shown that M. fortuitum infection in-
duced approximately 15 per cent. M. avium and M.
scrofulaceum infections induced approximately 50
per cent while M. kansasii infection induced ap-
proximately 70 per cent of the protective efficacy of
BCG14. In the present study, using a more precise
estimation. i.e., BE-spleen, the reduction of 2.1 log10
cfu of SILV in spleen at 2 wk after challenge in the
animals immunised with BCG compared to that in
the control animals as 100 per cent protection, 23.8.
81 and 90.5 per cent protection was seen in the
animals exposed to MACsd, MACso and MACsp,
respectively, indicating that the standard strain of
MAC maintained in the laboratory induced a lower
protective effect compared to the other strains. Simi-
larly, 33.3 per cent protection was seen in the ani-
mals exposed to the M. fortuitum complex strain.
Palmer and Long14 had earlier reported that the pro-
tection induced by M. fortuitum was 15 per cent of
that induced by BCG. At 6 wk after challenge, 100
per cent protection was seen in the animals
immunised with BCG and the challenge organisms
could not be detected in their spleens. On the other
hand, the resistance to dissemination of infection to
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the spleen in the animals immunised with different
strains of MAC was not greater than that seen in the
control animals and viable challenge organisms could
still be detected in their spleens.
The guineapigs used in the present study seemed
to have a high degree of natural resistance to myco-
bacterial infection as seen by the reduction in BE-
spleen even in the control animals by 6 wk after
challenge in the absence of any evidenced of prior
exposure to mycobacterial antigens as evidenced by
the negligible skin test response to PPD-RT23 and
PPD-B in these animals. Mitchison et al 10 have al-
ready noted in the 1960s that the M-strain guineapigs
might differ in their susceptibility to tuberculosis,
and it is possible that this difference has become
more marked over the years15,16.
In the present study, prior exposure either to MAC
or M. fortuitum was not seen to have any modulatory
effect on the protective immunity due to BCG in the
early course of challenge infection since the number
of challenge organisms recovered from spleen at 2
wk after infection in animals sensitised with MAC or
M. fortuitum prior to immunisation with BCG was
comparable to that observed in the animals
immunised with BCG alone. Other workers17,18 have
also observed similar absence of any modulation due
to prior sensitisation with MAC on the protective
effect of BCG. The hypothesis that oral immunisation
with MAC might induce tolerance which might in-
terfere with the immune response to subsequent BCG
was examined in an earlier study” carried out at the
TRC, Madras. It was found that oral exposure with
MAC did not interfere with the protective immunity
induced by BCG. However, at 6 wk after challenge
in the present study. modulation of protective re-
sponse resulting from BCG was observed in the
animals sensitiscd with either MAC from soil or M.
fortuitum from soil and viable challenge organisms
were recovered from the spleens of these animals
while in all the other animals, except the controls,
which were directly challenged, the challenge organ-
isms could not be detected in the spleen by this point
of time.
Abrahams20 first suggested that the initial myco-
bacterial infection may set the reaction pattern to
subsequent mycobacterial infections. Later, Stanford
and Rook21 suggested that there may be two types of
cell mediated responses to mycobacteria, one of them,
the Listeria-type being protective and the other, the
Koch-type leading to adverse reactions to subsequent
mycobacterial infections. It may be possible to un-
derstand the basis for the observed differences in the
immunogenicity of MAC strains by using techniques
such as DNA fingerprinting, RNA typing, plasmid
profile, isoenzyme pattern, etc., to study these strains
at the molecular level. In a comparison of drug sus-
ceptibility of MAC isolates from AIDS patients in
British Columbia with those from animals, isolates
from patients were more susceptible as compared to
those from animals22. Further frequency of plasmids
has been found to be much higher in clinical and
aerosol isolates of M. avium, M. intracellulare and
M. scrofulaceum as compared to those from soil.
dust, sediment and water23. Such differences could
also be occurring in the antigenic composition and
immunogenicity of MAC isolates from different
sources, and these differences might have been re-
sponsible for the differences in the immune response
and immune modulation induced by the different
strains in the present study.
Though many studies have been done using ani-
mal models to investigate the effect of nontuberculous
mycobactcrial infections on the protective response
induced by subsequent BCG vaccination11,13-15,17-19,
they have mainly relied on standard strains and have
not attempted a comparison between wild-type strains
of the same species obtained from different sources.
This was attempted in the present study for the first
time to our knowledge. from an area where a large
scale BCG trial was conducted. Future studies using
these isolates may need to focus on the effect of
multiple exposures and aerosol infections with these
mycobacteria on subsequent protective response
which would be more simulatory of the actual se-
quence of events taking place in man24.
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